News that the U.S. Food and Drug Administration (FDA) is to hold a public hearing next month to consider greater oversight of stem cell clinics operating in the country is as welcome as it is late. I say “late” because, while the regulators have been twiddling their fingers, the stem cell business has been booming across America.
Complete story
https://multiplesclerosisnewstoday.c...and-other-ills
Complete story
https://multiplesclerosisnewstoday.c...and-other-ills
Comment